Pertussis Infection in the United States: Role for Vaccination of Adolescents and Adults

References

1. ↵
   Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from 10-year community study. BMJ 1988; 296: 612–4.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Mikelova LK, Halperin SA, Scheifele D, et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143: 576–81.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   De Serres G, Shadami R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174–9.

   OpenUrlAbstract/FREE Full Text
4. ↵
   Lee GM, Lett S, Schauer S, et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004; 39: 1572–80.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Hewlett EL. Bordetella species. In: Principles and Practice of Infectious Diseases. 5th ed. (Mandel GL, Bennett JE, Dolin R, eds). Philadelphia, PA: Churchill Livingstone; 2000, p. 2414–22.
6. ↵
   Cherry JD. Pertussis in preantibiotic and prevaccine era, with an emphasis on adult pertussis. Clin Infect Dis 1999; 28: S107–S11.

   OpenUrlCrossRefPubMed
7. ↵
   Centers for Disease Control and Prevention. Pertussis: United States, 1997–2000. MMWR 2002; 51: 73–6.

   OpenUrlPubMed
8. ↵
   Centers for Disease Control and Prevention. Historical summaries of notifiable diseases in the United States. MMWR 2005; 52.
9. ↵
   Centers for Disease Control and Prevention. National Immunization Program. Pertussis Surveillance Report, 2004 (Final). August 12, 2005. Unpublished data.
10. ↵
    Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985–1988. Evaluation of the completeness of national reporting. JAMA 1992; 267: 386–91.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555–63.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 1965; 80: 365–9.

    OpenUrlPubMedWeb of Science
13. ↵
    Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordatella pertussis infections: a study of persons ages 1–65 years. J Infect Dis 1996; 173: 1256–9.

    OpenUrlAbstract/FREE Full Text
14. ↵
    Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11: 1045–53.

    OpenUrlCrossRefPubMed
15. ↵
    Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115: 1422–7.

    OpenUrlAbstract/FREE Full Text
16. ↵
    Jackson LA, Cherry JD, Wang SP, Grayston ST. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis 2000; 31: 3–6.

    OpenUrlAbstract/FREE Full Text
17. ↵
    Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672–4.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Infect Dis 2001; 183: 1353–9.

    OpenUrlAbstract/FREE Full Text
19. ↵
    Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004; 23: 985–9.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology. J Infect Dis 1990; 161: 473–9.

    OpenUrlFREE Full Text
21. ↵
    Halperin SA, Wang EE, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991–1997: Report of the Immunization Monitoring Program: Active (IMPACT). Clin Infect Dis 1999; 28: 1238–43.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Izurieta HS, Kenyon TA, Strebel PM, et al. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996; 22: 503–7.

    OpenUrlAbstract/FREE Full Text
23. ↵
    Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J 1997; 16: S78–S84.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 9th ed.; 2006.
25. ↵
    Tanaka M, Vitek CR, Pascual FB, et al. Trends in pertussis among infants in the United States, 1980–1999. JAMA 2003; 290: 2968–75.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22: 628–34.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    Lindgren C, Milerad J, Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur J Pediatr 1997; 156: 405–9.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    Heininger U, Kleemann WJ, Cherry JD, et al. A controlled study of the relationship between bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004; 114: 9–15.

    OpenUrlAbstract/FREE Full Text
29. ↵
    Brooks DA, Edwards KM, Long SS, et al. The Rise of Adolescent Pertussis in the United States. Adv Stud Med 2005; 5: S450–S452.

    OpenUrl
30. ↵
    Centers for Disease Control and Prevention. Recommended antimicrobial agents for treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR 2005; 54: 1–16.

    OpenUrlPubMed
31. ↵
    Tozzi AE, Celentano LP, Ciofi degli Atti ML, et al. Diagnosis and management of pertussis. CMAJ 2005; 172: 509–15.

    OpenUrlAbstract/FREE Full Text
32. ↵
    Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic, and serologic perspectives. Ped Infect Dis J 2005; 24: S25–S34.

    OpenUrlCrossRef
33. ↵
    Bortolussi R, Miller B, Ledwith M, et al. Clinical course of pertussis in immunized children. Ped Infect Dis J 1995; 14: 870–874.

    OpenUrlCrossRef
34. ↵
    Pines E, Barrand M, Fabre P, et al. New acellular pertussis-containing paediatric combined vaccines. Vaccine 1999; 17: 1650–6.

    OpenUrlPubMed
35. ↵
    Boostrix® Prescribing Information. GlaxoSmithKline; 2005.
36. ↵
    Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005; 293: 3003–11.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    Centers for Disease Control and Prevention. ACIP recommends adolescent vaccination for tetanus, diphtheria and pertussis vaccine, June 30, 2005. Available at: www.cdc.gov/nip/pr/pr_tdap_jun2005.htm
38. ↵
    Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR 1997; 46: 1–25.

    OpenUrlPubMed
39. ↵
    Centers for Disease Control and Prevention. ACIP votes to recommend use of combined tetanus, diphtheria, and pertussis (Tdap) vaccine for adults, March 2, 2006. Available at: www.cdc.gov/nip/vaccine/tdap/tdap_adult_recs.pdf
40. ↵
    Kandola K, Lea A, Santos M. Pertussis rates in Northwest Territories after introducing adult formulation acellular vaccine (abstract). Can J Infect Dis Med Microbiol 2004; 15: 351.

    OpenUrl
41. ↵
    Pertussis in Newfoundland and Labrador: 1991–2004. CCDR 2005; 31: 235–7.

    OpenUrl